Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
RTW Investments10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/22 | 500,000 sh | $16.00 | $8,000,000 | +4.9% |
Roderick Wong10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/22 | 500,000 sh | $16.00 | $8,000,000 | +4.9% |
Bain Capital Investors10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |
Adam KoppelDirector | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% |
Bain Capital Life Sciences Investors10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% |
Andrew T. KaplanDirector | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |
Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% | |
Bain Capital Life Sciences Fund IV10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% |
BCLS Fund IV Investments10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% |
BCLS Fund IV Investments GP10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 1,562,500 sh | $16.00 | $25,000,000 | +7.4% |
Bain Capital Fund XIV10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |
Bain Capital XIV General Partner10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |
Bcpe Perseus Investor GP10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |
Bcpe Perseus Investor10% Owner | Kailera TherapeuticsKLRA | Open-market buy | 04/20 | 04/20 | 8,398,438 sh | $16.00 | $134,375,008 | +47.0% |